(PharmaNewsWire.Com, January 22, 2018 ) The Global PEGylated Proteins Market was worth USD 690.6 million in 2016 and estimated to be growing at a CAGR of 10.50%, to reach USD 1.137 billion by 2021. The market is showing great potential in the forecast period, i.e. till 2021. PEGylation is a process of attachment of covalent or non-covalent bond of PolyEthylene Glucol (PEG) polymer chains to molecules and macrostructures, like protein in case of PEGylation of proteins. PEGylated Proteins have become very important because PEGylation of proteins help to protect protein against enzymatic dehydration and it also increases the half-life of drugs.
Increasing R&D investments on pharmaceuticals and healthcare sector, high risk of diseases, increase in adoption of protein based drugs over non-protein based drugs and increased half-life of drugs due to PEGylation are the major driving factors of this market. On the other hand, the unpredictable accumulation of high molecular weight compounds in liver might lead to inclusion bodies with no known consequences. Furthermore, chain length of these compounds can change which might lead to unexpected clearance times in vivo. These concerning matters are challenging this market.
The Global market for PEGylated Proteins is broadly categorized into Protein Type, Services, Applications, consumable and by end-users. On the basis of Protein types, it is further sub-categorized into Interferons, erythropoietin and mAbs. On the basis of Applications, It is sub-categorized into Chronic Kidney Disease and Cancer treatment applications. On the basis of consumables, it is segmented into Reagents and PEGylation kits. On the basis of End-Users, it is analysed under Pharmaceutical & Biotechnology Companies, CROs and academic research institutes. On the basis of End-Users, Pharmaceutical & Biotechnology Companies are the biggest sector for this market.
Geographically, this market has been sub-categorized into North America, Latin America, Middle East & Africa, Asia-Pacific and Europe. On the basis of market share, North America is leading the charge with more than 30% of the global PEGylated Proteins Market. Asia-Pacific region is growing at the fastest rate in terms of CAGR followed by Latin America.
Some of the major companies dominating the market, by their products and services include Laysan Bio, Ltd., Iris Biotech GmbH, Biomatrik Inc., Quanta BioDesign Ltd., Cealares GmbH, Creative PEGworks, Jenkem Technology USA Inc., NOF Corporation, Thermo Fisher Scientific Inc., and Merck Millipore.
About Us: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialties with competitive pricing options.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
